1. Gooley JJ, Lu J, Fischer D, Saper CB. A broad role for melanopsin in nonvisual photoreception. J Neurosci 1991;23:7093-7106.
2. Deurveilher S, Semba K. Indirect projections from the suprachiasmatic nucleus to major arousal-promoting cell groups in rat: implications for the circadian control of behavioural state. Neuroscience 2005;130:165-183.
3. Aston-Jones G, Chen S, Zhu Y, Oshinsky ML. A neural circuit for circadian regulation of arousal. Nat Neurosci 2001;4:732-738.
4. Saper CB, Lu J, Chou TC, Gooley J. The hypothalamic integrator for circadian rhythms. Trends Neurosci 2005;28:152-157.
5. Lewy AJ, Cutler NL, Sack RL. The endogenous melatonin profile as a marker for circadian phase position. J Biol Rhythms 1999;14:227-236.
6. Buijs RM, Wortel J, Van Heerikhuize JJ, Feenstra MG, Ter Horst GJ, Romijn HJ, Kalsbeek A. Anatomical and functional demonstration of a multisynaptic suprachiasmatic nucleus adrenal (cortex) pathway. Eur J Neurosci 1999;11:1535-1544.
7. Berridge CW, Foote SL. Effects of locus coeruleus activation on electroencephalographic activity in neocortex and hippocampus. J Neurosci 1991;11:3135-3145.
8. Franken P, Dijk DJ, Tobler I, Borberly AA. Sleep deprivartion in the rat: Effects of EEG power spectra, vigilence states, and cortical temperature. Am J Physiol 1991;261:198-208.
9. Ko EM, Estabrooke IV, McCarthy M, Scammell TE. Wake-related activity of tuberomammillary neurons in rats. Brain Res 2003;992:220-226.
10. Gallopin T, Fort P, Eggermann E, Cauli B, Luppi PH, Rossier J, Audinat E, Mühlethaler M, Serafin M. Identification of sleep-promoting neurons in vitro. Nature 2000;404:992-995.
11. Sherin JE, Shiromani PJ, McCarley RW, Saper CB. Activation of ventrolateral preoptic neurons during sleep. Science 1996;271:216-219.
12. Gallopin T, Luppi PH, Cauli B, Urade Y, Rossier J, Hayaishi O, Lambolez B, Fort P. The endogenous somnogen adenosine excites a subset of sleep-promoting neurons via A2A receptors in the ventrolateral preoptic nucleus. Neuroscience 2005;134:1377-1390.
13. Basheer R, Strecker RE, Thakkar MM, McCarley RW. Adenosine and sleep-wake regulation. Prog Neurobiol 2004;73:379-396.
14. Obal F Jr, Krueger JM. Biological Regulation of Non-Rapid-Eye-Movement Sleep. Frontiers in Bioscience 2003;8:520-550.
15. Majde JA. Viral double-stranded RNA, cytokines and the flu. J Interferon Cytok Res 2000;20:259-272.
16. Yoshida H, Peterfi Z, Garcia-Garcia F, Kirkpatrick R, Yasuda T, Krueger JM. Asymmetries in slow wave sleep EEG induced by local application of TNFα. Brain Res 2004;1009:129-136.
17. McCann SM, Kimura M, Karanth S, Yu WH, Rettori V. Role of nitric oxide in the neuroendocrine response to cytokines. Front Horm Res 2002;29:117-129.
18. Luk WP, Zhang Y, White TD, Lue FA, Wu C, Jiang CG, Zhang L, Moldofsky H. Adenosine: a mediator of interleukin-1 beta-induced hippocampal synaptic inhibition. J Neurosci 1999;19:4238-4244.
19. Brown MR, McCubbin J, Kaufman P, Niemeroff C. Neuropeptide-mediated regulation of the neuroendocrine and autonomicn responses to stress. Stress, neuropeptides, and systemic disease 1991.
20. Chrousos GP, Gold PW. The concepts of stress and stress system disorders. J Am Med Assoc 1992;267:1244-1252.
21. McEwen BS, Sapolsky RM. Stress and cognitive function. Curr Opin Neurobiol 1995;5:205-216.
22. Born J, Hansen K, Marshall L, Molle M, Fehm HL. Timing the end of nocturnal sleep. Nature 1999;397:29-30.
23. Born J, Fehm H. Hypothalamus-pituitary-adrenal activity during human sleep: a coordinating role for the limbic hippocampal system. Exp Clin Endocrinol Diabetes 1998;106:153-163.
24. Meerlo P, Pragt B, Daan S. Social stress induces high intensity sleep in rats. Neurosci Lett 1997;255:41-44.
25. Marinesco S, Bonnet C, Cespuglio R. Influence of stress duration on the sleep rebound induced by immobilization in the rat: a possible role for corticosterone. Neuroscience 1999;92:921-933.
26. Bierhaus A, Wolf J, Andrassy M, Rohleder N, Humpert PM, Petrov D. A mechanism converting psychosocial stress into mononuclear cell activation. Proc Natl Acad Sci USA 2003;100:1920-1925.
27. Benschop RJ, Godaert GL, Geenen R, Brosschot JF, De Smet MB, Olff M, Heijnen CJ, Ballieux RE. Relationships between cardiovascular and immunological changes in an experimental stress model. PsycholMed 1995;25:323-327.
28. Kiecolt-Glaser JK, Glaser R. Psychoneuroimmunology and health consequences: data andshared mechanisms. Psychosom Med 1995;57:269-274.
29. Irwin M, Smith TL, Gillin JC. Electroencephalographic sleep and natural killer activity in depressed patients and control subjects. Psychosom Med 1992;54:10-21.
30. Braun AR, Balkin TJ, Wesenten NJ, Carson RE, Varga M, Baldwin P, Selbie S, Belenky G, Herscovitch P. Regional cerebral blood flow throughout the sleep-wake cycle. Brain 1997;120:1173-1197.
31. Bonnet MH, Arand DL. 24-Hour metabolic rate in insomniacs and matched normal sleepers. Sleep 1995;18:581-588.
32. Vgontzas AN, Bixler EO, Lin HM, Prolo P, Mastorakos G, Vela-Bueno A, Kales A, Chrousos GP. Chronic insomnia is associated with nyctohemeral activation of the hypothalamic-pituitary-adrenal axis: clinical implication. J Clin Endocrinol Metab 2001;86:3787-3794.
33. Renko AK, Hiltunen L, Laakso M, Rajala U, Keinanen-Kiukaanniemi S. The relationship of glucose tolerance to sleep disorders and daytime sleepiness. Diabetes Res Clin Pract 2005;67:84-91.
34. Spiegel K, Tasall E, Penev P, Van Cauter E. Brief communication: sleep curtailment in healthy young men is associated with decreased leptin levels, elevated ghrelin levels, and increased hunger and appetite. Ann Intern Med 2004;141:846-850.
35. Weller L, Avinir O. Hassles, uplifts and quality of sleep. Percept Mot Skills 1993;76:571-576.
36. Hick RA, Garcia ER. Level of stress and sleep duration. Percept Mot Skills 1987;64:44-46.
37. Bastien CH, Vallieres A, Morin CM. Precipitating factors of insomnia. Behav Sleep Med 2004;2:50-62.
38. Quan SF, Katz R, Olson J, Bonekat W, Enright PL, Young T, Newman A. Factors associated with incidence and persistence of symptoms of disturbed sleep in an elderly cohort: the Cardiovascular Health Study. Am J Med Sci 2005;329:163-172.
39. Morin CM, Rodrigue S, Ivers H. Role of stress, arousal, and coping skills in primary insomnia. Psychosom Med 2003;65:259-267.
40. Vgontzas AN, Papanicolaou DA, Bixler EO, Lotsikas A, Zachman K, Kales A, Prolo P, Wong ML, Licinio J, Gold PW, Hermida RC, Mastorakos G, Chrousos GP. Circadian interleukin-6 secretion and quantity and depth of sleep. J Clin Endocrinol Metab 1999;84:2603-2607.
41. Lamarche CH, Ogilvie RD. Electrophysiological changes during the sleep onset period of psychophysiological insomniacs, psychiatric insomniacs, and normal sleepers. Sleep 1997;20:724-733.
42. Nofzinger EA, Buysse DJ, Germain A, Price JC, Miewald JM, Kupfer DJ. Functional neuroimaging evidence for hyperarousal in insomnia. Am J Psychiatry 2004;161:2126-2128.
43. Spielman AJ, Caruso LS, Glovinsky PB. A behavioral perspective on insomnia treatment. Psychiatr Clin North Am 1987;10:541-553.
44. Morin CM. In: Morin CM, editor. A cognitive-behavioral model of chronic insomnia. Insomnia: Psychological Assessment and Managemen 1993;New York: Guilford.
45. Espie CA. Insomnia: conceptual issues in the development, persistence, and treatment of sleep disorder in adults. Annu Rev Psychol 2002;53:215-243.
46. Edinger JD, Fins AI, Glenn DM, Sullivan RJ Jr, Bastian LA, Marsh GR, Dailey D, Hope TV, Young M, Shaw E, Vasilas D. Insomnia and the eye of the beholder: are there clinical markers of objective sleep disturbances among adults with and without insomnia complaints? J Consult Clin Psychol 2000;68:586-593.
47. American Psychiatric Association. Diagnostic and Statistical manual of mental disorders 1995;4th ed (Korean translation version). Seoul: Hana medical publishing.
48. Ohayon MM, Shapiro CM. Sleep disturbances and psychiatric disorders associated with posttraumatic stress disorder in the general population. Compr Psychiatry 2000;41:469-478.
49. Yehuda R, Teicher MH, Trestman RL, Levengood RA, Siever LJ. Cortisol regulation in posttraumatic stress disorder and major depression: a chronobiological analysis. Biol Psychiatry 1996;40:79-88.
50. Mellman T, Kumar A, Kulick-Bell R, Kumar M, Nolan B. Nocturnal/daytime urine noradrenergic measures and sleep in combat-related PTSD. Biol Psychiatry 1995;38:174-179.
51. Husain AM, Miller PP, Carwile ST. REM sleep behavior disorder: potential relationship to posttraumatic stress disorder. J Clin Neurophysiol 2001;18:148-157.
52. Germain A, Buysse DJ, Nofzinger E. Sleep-specific mechanisms underlying posttraumatic stress disorder: Integrative review and neurobiological hypotheses. Sleep Med Rev 2008;12:185-195.
53. Han KS. Stress of mid-life stage. Korean J Stress Res 2007;15:263-270.
54. Seaward BL. Managing stress-principles and strategies for health and well-being 2009;6th ed. Boston: Jones and Bartlett Pub.
55. National Institutes of Health State of the Science Conference statement on Manifestations and Management of Chronic Insomnia in Adults. Sleep 2005;28:1049-1057.
56. McKernan RM, Whiting PJ. Which GABAA-receptor subtypes really occur in the brain? Trends Neurosci 1996;19:139-143.
57. Zhdanova IV. Advances in the management of insomnia. Expert Opin Pharmacother 2004;5:1573-1579.
58. Bressler R, Bahl JJ. Principles of drug therapy for the elderly patient. Mayo Clin Proc 2003;78:1564-1577.
59. Roehrs T, Merlotti L, Zorick F, Roth T. Sedative, memory, and performance effects of hypnotics. Psychopharmacology 1994;116:130-134.
60. Sepracor I. Lunesta (eszopiclone tablets) product information 2005;Marlborough, MA.
61. Miyamoto M, Nishikawa H, Doken Y, Hirai K, Uchikawa O, Ohkawa S. The sleep-promoting action of ramelteon (TAK-375) in freely moving cats. Sleep 2004;27:1319-1325.
62. Chavez B. Pharmacotherapy in managing insomnia: Assessing patient needs and outcomes. US Pharm 2005;2:HS23-HS26.
63. Aronson MD, Hafez H. A case of trazodone-induced ventricular tachycardia. J Clin Psychiatry 1986;47:388-389.
64. Sproule BA, Busto UE, Buckle C, Herrmann N, Bowles S. The use of non-prescription sleep products in the elderly. Int J Geriatr Psychiatry 1999;14:851-857.
65. Spoormaker VI, Montgomery P. Disturbed sleep in post-traumatic stress disorder: Secondary symptom or core feature? Sleep Medicine Reviews 2008;12:169-184.
66. Chesson AL Jr, Anderson WM, Littner M, Davila D, Hartse K, Johnson S, Wise M, Rafecas J. Practice parameters for the nonpharmacologic treatment of chronic insomnia. Sleep 1999;22:1128-1133.
67. Spielman AJ, Saskin P, Thorpy MJ. Treatment of chronic insomnia by restriction of time in bed. Sleep 1987;10:45-56.
68. Hauri P. Current concepts: the sleep disorders 1977;. Kalamanzoo MI: The Upjohn Company.
69. Morin CM, Colecchi C, Stone J, Sood R, Brink D. Behavioral and pharmacological therapies for late-life insomnia: a randomized controlled trial. JAMA 1999;281:991-999.
70. Edinger JD, Wohlgemuth WK, Radtke RA, Marsh GR, Quillian RE. Cognitive behavioral therapy for treatment of chronic primary insomnia: a randomized controlled trial. JAMA 2001;285:1856-1864.